|  Help  |  About  |  Contact Us

Publication : Seipin ablation in mice results in severe generalized lipodystrophy.

First Author  Cui X Year  2011
Journal  Hum Mol Genet Volume  20
Issue  15 Pages  3022-30
PubMed ID  21551454 Mgi Jnum  J:173404
Mgi Id  MGI:5013999 Doi  10.1093/hmg/ddr205
Citation  Cui X, et al. (2011) Seipin ablation in mice results in severe generalized lipodystrophy. Hum Mol Genet 20(15):3022-30
abstractText  Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2) is an autosomal recessive disorder characterized by an almost complete loss of adipose tissue, insulin resistance and fatty liver. Here, we create the first murine model of BSCL2 by targeted disruption of seipin, the causative gene for BSCL2. Compared with their wild-type littermates, the seipin(-/-) mice are viable and of normal weight but display significantly reduced adipose tissue mass, hepatic steatosis, glucose intolerance and hyperinsulinemia. The levels of leptin and adiponectin were both significantly decreased in seipin(-/-) mice, so were non-esterified fatty acids upon fasting. Surprisingly, however, hypertriglyceridemia which is common in human BSCL, was not observed in seipin(-/-) mice. Our findings suggest a possible tissue-autonomous role of seipin in liver lipid storage. The availability of the seipin(-/-) mice should help elucidate the molecular function of seipin and lead to a better understanding of the many metabolic consequences of human BSCL2.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

11 Bio Entities

Trail: Publication

0 Expression